Terazosin |
Hytrin |
DB01162 |
1-(4-AMINO-6,7-DIMETHOXYQUINAZOLIN-2-YL)-4-[[(2RS)-2,3,4,5-TETRAHYDROFURAN-2-YL]CARBONYL]PIPERAZINE |
METHANONE, [4-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-1-PIPERAZINYL](TETRAHYDRO-2-FURANYL)- |
6,7-DIMETHOXY-2-[4-(TETRAHYDRO-2-FURANYLCARBONYL)-1-PIPERAZINYL]-4-QUINAZOLINAMINE # |
6,7-DIMETHOXY-2-[4-(OXOLANE-2-CARBONYL)PIPERAZIN-1-YL]-3,4-DIHYDROQUINAZOLIN-4-IMINE |
1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(2-TETRAHYDROFUROYL)-PIPERAZINE |
[4-(4-AMINO-6,7-DIMETHOXY-QUINAZOLIN-2-YL)PIPERAZIN-1-YL]-TETRAHYDROFURAN-2-YL-METHANONE |
6,7-DIMETHOXY-2-[4-(OXOLANE-2-CARBONYL)PIPERAZIN-1-YL]QUINAZOLIN-4-AMINE |
1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(2-TETRAHYDROFUROYL)PIPERAZINE |
FT-0630739 |
KB-147102 |
H963 |
AN-38972 |
NCGC00016026-11 |
NCGC00016026-05 |
NCGC00016026-04 |
1- 4-[ CARBONYL]PIPERAZINEHYDROCHLORIDE |
VA11839 |
NC00689 |
MCULE-4030111564 |
CS-2429 |
CCG-205212 |
AKOS005266642 |
DAP000371 |
BDBM50033111 |
BBL010743 |
4097AH |
HY-B0371 |
HMS3371E20 |
HMS3369P14 |
HMS3259F04 |
HMS2232N21 |
MOLPORT-001-684-489 |
MET029 |
GTPL7302 |
MLS006011889 |
REGID_FOR_CID_5401 |
SCHEMBL6528 |
CID5401 |
HYTRINREG |
TERAZOSABB |
6,7-BIS(METHYLOXY)-2-[4-(TETRAHYDROFURAN-2-YLCARBONYL)PIPERAZIN-1-YL]QUINAZOLIN-4-AMINE |
[4-(4-AMINO-6,7-DIMETHOXYQUINAZOLIN-2-YL)PIPERAZIN-1-YL]-(OXOLAN-2-YL)METHANONE |
[4-(4-AMINO-6,7-DIMETHOXYQUINAZOLIN-2-YL)PIPERAZIN-1-YL](TETRAHYDROFURAN-2-YL)METHANONE |
MLS001305722 |
BRD-A22256192-003-03-7 |
L000692 |
A-45975 |
PIPERAZINE, 1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-((TETRAHYDRO-2-FURANYL)CARBONYL)- |
6,7-DIMETHOXY-2-[4-(TETRAHYDROFURAN-2-YLCARBONYL)PIPERAZIN-1-YL]QUINAZOLIN-4-AMINE |
D08569 |
C07127 |
70024-40-7 (MONO-HYDROCHLORIDE, DIHYDRATE) |
1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(TETRAHYDRO-2-FUROYL)PIPERAZINE |
LS-110234 |
SMR000058309 |
CPD000058309 |
AC-11120 |
NCGC00025191-03 |
NCGC00016026-08 |
TERAZOSIN HCL |
STK567029 |
A 45975 |
63074-08-8 (HYDROCHLORIDE) |
VCKUSRYTPJJLNI-UHFFFAOYSA-N |
STOCK4S-28262 |
BPBIO1_000840 |
MLS001201836 |
MLS000069703 |
UNII-8L5014XET7 |
SPBIO_002701 |
BSPBIO_000762 |
LOPAC0_001138 |
AC1L1K9W |
PRESTWICK3_000751 |
PRESTWICK2_000751 |
PRESTWICK1_000751 |
PRESTWICK0_000751 |
C19H25N5O4 |
CHEBI:9445 |
VICARD |
ITRIN |
HYTRINEX |
TERAZOSIN (INN) |
TERAZOSABB (TN) |
TRAZOSIN HCL |
TERAZOSIN [INN:BAN] |
HYTRACIN |
TERAZOSINA [INN-SPANISH] |
TERAZOSINUM [INN-LATIN] |
TERAZOSINE [INN-FRENCH] |
ZAYASEL |
63590-64-7 |
VASOMET |
TERAZOSINUM |
TERAZOSINA |
BLAVIN |
FOSFOMIC |
FLUMARC |
TERAZOSINE |
5401 |
SAM002589982 |
HMS2090P21 |
9337 |
178103875 |
7302 |
318164856 |
COMPOUND 3 [PMID: 27347366] |
FDA Approval | 1987 |
Drug Class | small molecule |
Drug Indications | antihypertensive agents |
Drug Indications | Antineoplastic Agents |
Drug Class | antineoplastic agents |
Year of Approval | 1987 |
Drug Class | antihypertensive agents |
antagonist |
Trial Name | - |
Novel drug target | Established target |
antagonist |
Trial Name | - |
Novel drug target | Established target |
Specific Action of the Ligand | Antagonist |
antagonist |
Trial Name | - |
Novel drug target | Established target |
Specific Action of the Ligand | Antagonist |
inhibitor |
Specific Action of the Ligand | Inhibition |
Endogenous Drug? | False |
Direct Interaction? | True |
TERAZOSIN | Primary Drug Name |
Drug Class | antihypertensive agents |
Year of Approval | 1987 |
Drug Class | antineoplastic agents |
Drug Indications | Antineoplastic Agents |
Drug Indications | antihypertensive agents |
Drug Class | small molecule |
HMS2090P21 | Drug Synonym |
SAM002589982 | Drug Synonym |
TERAZOSIN | pubchem_primary_name |
TERAZOSINUM [INN-LATIN] | Drug Synonym |
CHEBI:9445 | Drug Synonym |
63074-08-8 (HYDROCHLORIDE) | Drug Synonym |
TERAZOSIN | GuideToPharmacology Ligand Name |
178103875 | PubChem Drug SID |
COMPOUND 3 [PMID: 27347366] | GuideToPharmacology Ligand Name |
318164856 | PubChem Drug SID |